Not logged in.png)
Share.png)
SaveShare Save Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary End Points From the EMBARK Trial
Shore, Neal D.; Gleave, Martin; De Giorgi, Ugo; Rannikko, Antti; Pieczonka, Christopher M.; Sridharan, Swetha; Brasso, Klaus; Woo, Henry H.; Gomez Caamano, Antonio; Saranchuk, Jeff W.; Nordquist, Luke T.; Ferreira, Ubirajara; Tang, Yiyun; Rosbrook, Brad; Haas, Gabriel P.; Rosales, Matt; Zohren, Fabian; Tarazi, Jamal; Freedland, Stephen J. Share Save Effects of renal impairment on the pharmacokinetics, safety, and tolerability of pudexacianinium (ASP5354) after IV administration: a mechanistic explorationKojima, Tomoki; Saito, Masako; Matsuda, Toshihiro; Simmons, Neal; Nagata, Masanori; Miyagawa, Mayuko; Wojtkowski, Tomasz; Guro, Sayuri; Koibuchi, Akira; Cruz, Kimberly S.; Neutel, Joel M.; Free, Almena L.; Sekino, Hisakuni; Haas, Gabriel P.; Takusagawa, Shin Share Save society for medical publication professionals survey and industry policies reviewCullinan, Emily; Banner, Steve; Harrold, Nicole; Govender, Melanie; Tulley, Shaun; Smith, Sherri; Kelly, Kyoko; McCarthy, Emma; Kamboj, Shilpa; Raynsford, Eleanor J.; Donaldson-Jones, Jessica; Valentine, Doreen; Toroser, Dikran Share Save Share Save Does Physician Documentation of Patients' Prostate-Specific Antigen Doubling Time Affect Treatment Decisions in High-Risk Biochemically Recurrent Prostate Cancer?Morgans, Alicia K.; Touya, Maelys; El-Chaar, Nader; Elsouda, Dina; Mucha, Lisa; Ramaswamy, Krishnan; Adejumo, Kelechi L.; Schuler, Tammy; Sharpe, Jason; Feinberg, Bruce; Asgarisabet, Parisa; Pathak, Prathamesh; Freedland, Stephen J. Share Save Share Save Applications of in vitro transporter assays for mechanistic characterization and prediction of clinical drug-drug interactions☆Heredi-Szabo, Krisztina; Ito, Sumito; Liang, Xiaomin; Park, Yeojin; Parvez, Masud; Sandoval, Philip; Shen, Hong; Staiger, Kelly M.; Tetsuka, Kazuhiro; Warren, Mark S.; Zou, Ling; Lai, Yurong Share Save Highlights of the 16th Japan Bioanalysis Forum symposiumYamada, Naohito; Niwa, Makoto; Hara, Hisanori; Ibushi, Tsubasa; Koyama, Noriyuki; Miyayama, Takashi; Nagata, Masanori; Ohashi, Yohei; Ohyama, Tomofumi; Okuzono, Takeshi; Shimada, Eiichi; Shimizu, Hiroyuki; Takahashi, Makoto; Takamatsu, Yuki; Yamamoto, Ken-ichi; Fukunaga, Chie; Harada, Hideki; Ide, Ryosuke; Kawahara, Tsuyoshi; Kurisu, Hironosuke; Mizuochi, Masayoshi; Nakase, Yoshihiro; Oka, Tomohiro; Otsuka, Yukihiro; Yamazaki, Makoto; Yasui, Kento Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Discovery of ASP2453, a potent and orally bioavailable covalent inhibitor of KRAS G12C for the treatment of solid tumorsImaizumi, Tomoyoshi; Imanishi, Masashi; Yamaki, Susumu; Shimada, Itsuro; Satake, Yoshiki; Nigawara, Takahiro; Koike, Takanori; Yamanaka, Yosuke; Amano, Yasushi; Mori, Kenichi; Nakayama, Ayako; Nishizono, Yoshihiro; Shimazaki, Masashi; Nagashima, Takeyuki; Kuramoto, Kazuyuki Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
